[mattkrause]

> proving a new use for an out-of-patent drug is a lot of work for very little money.

That's not entirely true. There are programs in the US and UK which offer "marketing exclusivity" for companies that perform trials validating new uses for existing drugs. These aren't exactly patents, but it does provide a financial incentive.